Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -0.37% | 86.27 | 1.3% | $1352.68m | |
| AMGN | Amgen Inc. | 0.97% | 203.88 | 1.2% | $612.82m | |
| GILD | Gilead Sciences, Inc. | 0.77% | 69.18 | 0.9% | $531.67m | |
| LOXO | Loxo Oncology Inc | 0.11% | 233.50 | 12.7% | $525.80m | |
| BIIB | Biogen Inc. | -0.27% | 337.42 | 1.3% | $408.79m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.19% | 194.70 | 1.9% | $323.01m | |
| ILMN | Illumina, Inc. | 0.87% | 312.75 | 3.5% | $317.65m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.35% | 418.84 | 2.6% | $300.57m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.12% | 117.05 | 2.0% | $212.97m | |
| TSRO | TESARO, Inc. | 0.03% | 74.96 | 14.4% | $167.91m | |
| INCY | Incyte Corporation | -0.32% | 78.42 | 2.5% | $149.05m | |
| A | Agilent Technologies, Inc. | 2.10% | 72.31 | 1.5% | $147.46m | |
| EXAS | Exact Sciences Corporation | 4.19% | 78.80 | 25.3% | $141.72m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.22% | 122.80 | 15.4% | $135.00m | |
| LGND | Ligand Pharmaceuticals Incorporated | 6.49% | 117.90 | 23.1% | $126.49m |
Company Profile
Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT.